PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER

被引：0
|
作者：
Mesci, Aruz [1 ]
Isfahanian, Naghmeh [1 ]
Douvi, Georgia [1 ]
Gouran-Savadkoohi, Mohammad [1 ]
Dayes, Ian [1 ]
Lukka, Himanshu [1 ]
Quan, Kimmen [1 ]
Schnarr, Kara [1 ]
Goldberg, Mira [1 ]
Hallock, Abhirami [2 ]
Chow, Tom [1 ]
Diamond, Kevin [1 ]
Jakubovic, Raphael [2 ]
Thabane, Lahane [1 ]
Tsakiridis, Theodoros [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] McMaster Univ, St Catharines, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 163卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
151
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL
    Douvi, Georgia
    Isfahanian, Naghmeh
    Lukka, Himanshu
    IanDayes
    Quan, Kimmen
    Schnarr, Kara Lynne
    Goldberg, Mira
    Wright, Jim
    Hallock, Abhirami
    Ishkanian, Adrian
    Cuthbert, David
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean-Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S87 - S88
  • [2] Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
    Wang, Shih-Chang
    Ting, Wei-Chen
    Chang, Yun-Ching
    Yang, Ching-Chieh
    Lin, Li-Ching
    Ho, Hsiu-Wen
    Chu, Shou-Sheng
    Lin, Yu-Wei
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)
    Isfahanian, Naghmeh
    Lukka, Himanshu
    Dayes, Ian
    Quan, Kimmen
    Schnarr, Kara Lynne
    Douvi, Georgia
    Goldberg, Mira
    Wright, Jim
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : E410 - E415
  • [4] SBRT prostate cancer boost of 9 Gy, prospective phase II trial
    Ferrer Gonzalez, F.
    Pont, A.
    De Blas, R.
    Boladeras, A.
    Garin, O.
    Garcia Exposito, N.
    Stefanovic, M.
    Garcia Marqueta, M.
    Juarez, M.
    Olivas, M.
    Armijos, L.
    Alonso Becerra, M.
    Alvarez, A.
    Slocker, A.
    Ventura, M.
    Castells, M.
    Merino, E.
    Suarez, F.
    Gutierrez, C.
    Delgado, J.
    Zardoya, E.
    Najjari, D.
    Picon, C.
    Ferrer, M.
    Guedea, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1091 - S1092
  • [5] The early result of whole pelvic radiotherapy and stereotactic body radiotherapy boost for high-risk localized prostate cancer
    Lin, Yu -Wei
    Lin, Li -Ching
    Lin, Kuei-Li
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [6] HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CARCINOMA: FINAL RESULTS OF PHASE III RANDOMIZED TRIAL
    Yeoh, Eric E.
    Botten, Rochelle J.
    Butters, Julie
    Di Matteo, Addolorata C.
    Holloway, Richard H.
    Fowler, Jack
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1271 - 1278
  • [7] Stereotactic body radiotherapy (SBRT) versus high dose rate (HDR) brachytherapy (BT) boost for high-risk (HR) prostate cancer.
    Gonzalez-Motta, Alejandro
    Roach, Mack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments
    Mesci, Aruz
    Isfahanian, Naghmeh
    Dayes, Ian
    Lukka, Himu
    Tsakiridis, Theodoros
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : E25 - E38
  • [9] Whole Pelvic RT with SBRT boost Versus IMRT for Patients with High-Risk Localised Prostate Cancer
    Wang, S. C.
    Ting, W. C.
    Chang, Y. C.
    Yang, C. C.
    Lin, Y. W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S37 - S37
  • [10] Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
    Nicholls, Luke
    Suh, Yae-eun
    Chapman, Ewan
    Henderson, Daniel
    Jones, Caroline
    Morrison, Kirsty
    Sohaib, Aslam
    Taylor, Helen
    Tree, Alison
    van As, Nicholas
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 25 : 88 - 93
12345